The Business Research Company’s Oral Solid Dosage Contract Manufacturing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, July 24, 2024 /EINPresswire.com/ -- The oral solid dosage contract manufacturing market has experienced robust growth in recent years, expanding from $36.70 billion in 2023 to $39.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the growing global population, prevalence of chronic diseases, and rise in focus on research and development.

Strong Future Growth Anticipated
The oral solid dosage contract manufacturing market is projected to continue its strong growth, reaching $52.94 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing outsourcing by pharmaceutical companies, advancements in drug delivery technology, and increasing drug development activities.

Explore Comprehensive Insights Into The Global Oral Solid Dosage Contract Manufacturing Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16137&type=smp

Growth Driver Of The Oral Solid Dosage Contract Manufacturing Market
The increase in demand for generic drugs is expected to propel the growth of the oral solid dosage contract manufacturing market going forward. Generic drugs are medications that are bioequivalent to brand-name drugs in dosage, strength, safety, performance, quality, and intended use. The rising demand for generic drugs is attributed to patent expirations, cost containment efforts, regulatory incentives, and expanding access to healthcare. Oral solid dosage contract manufacturing significantly aids the production and distribution of generic drugs by leveraging the capabilities of contract manufacturers to enhance their operational efficiency, reduce costs, ensure high-quality production, and bring their products to market more swiftly and effectively.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Major Players And Market Trends
Key players in the oral solid dosage contract manufacturing market include Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG.

Major companies operating in the oral solid dosage contract manufacturing market are focused on developing innovative solutions, such as continuous manufacturing lines, to sustain their position in the market. A continuous manufacturing line refers to a production facility or system that utilizes continuous manufacturing processes to produce pharmaceuticals or other products.

Oral Solid Dosage Contract Manufacturing Market Segments:
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies

Geographical Insights: Asia-Pacific Leading The Market
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Oral Solid Dosage Contract Manufacturing Market Definition
Oral solid dosage contract manufacturing refers to outsourcing the production of oral solid dosage forms of pharmaceuticals to third-party manufacturers. This outsourcing strategy allows pharmaceutical companies to focus on their core activities, such as research, development, and marketing, while leveraging the expertise and capabilities of contract manufacturing organizations (CMO) to efficiently produce high-quality oral solid dosage pharmaceuticals.

Oral Solid Dosage Contract Manufacturing Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Oral Solid Dosage Contract Manufacturing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on oral solid dosage contract manufacturing market size, oral solid dosage contract manufacturing market drivers and trends, oral solid dosage contract manufacturing market major players, oral solid dosage contract manufacturing competitors' revenues, oral solid dosage contract manufacturing market positioning, and oral solid dosage contract manufacturing market growth across geographies. The oral solid dosage contract manufacturing market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Electronic Contract Manufacturing and Design Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/electronic-contract-manufacturing-and-design-services-global-market-report

Food Contract Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report

Medical Device Contract Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-device-contract-manufacturing-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn